(Q36304000)

13 August 2017

1 reference

title

Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice (English)

1 reference

13 August 2017

1 reference

Edith D Canby-Hagino

1

1 reference

13 August 2017

Ian M Thompson

series ordinal

2

1 reference

13 August 2017

publication date

1 May 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

255-261

1 reference

Cyclooxygenases in cancer: progress and perspective

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

5alpha-reductase activity in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Molecular mechanisms of lipopolysaccharide-induced cyclooxygenase-2 expression in human neutrophils: involvement of the mitogen-activated protein kinase pathway and regulation by anti-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

The contributions of cyclooxygenase-2 to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Primary chemoprevention of familial adenomatous polyposis with sulindac

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Sulindac and polyp regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

International trends and patterns of prostate cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Design of the Prostate Cancer Prevention Trial (PCPT).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Human cyclooxygenase-2 cDNA

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Human prostate cancer precursors and pathobiology.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Vioxx: an unequal partnership between safety and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

The selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Localized Prostate Cancer: Quality of Life Meets Whitmore's Legacy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0172

7 January 2021

Identifiers

DOI

10.1038/NCPONC0172

1 reference

13 August 2017

1 reference